Pharma News

Private equity activity in the pharmaceutical industry in France remained flat in 2023

In value terms, private equity deal activity in France increased by 8% in Q2 2023 compared with the previous quarter’s total of $101.1m and rose by 307% as compared to Q2 2022. Related deal volume remained flat in Q2 2023 versus the previous quarter and was 100% higher than in Q2 2022.

The top-ranked financial advisors supporting these private equity deals in France in Q2 2023 were Clearwater International Ltd (France); Deloitte Conseil; Germain Maureau with 1, 1, 1 deals respectively.

The top-ranked legal advisorss supporting these private equity deals in France Q2 2023 were McDermott Will & Emery; CMS Legal Services EEIG; DLA Piper with 2, 1, 1 deals respectively.

For further understanding of GlobalData’s Pharma Industry Mergers and Acquisitions Deals by Top Themes, buy the report here.

This content was updated on 18 July 2023

Source link
#Private #equity #activity #pharmaceutical #industry #France #remained #flat

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *